Drug Fix: Limiting Medicare Price Negotiation, More US FDA Adcomm And COVID-19 Vaccine Concerns

Pink Sheet reporters and editors discuss the impact of PhRMA’s new push to limit Medicare price negotiations, Congress’ interest in FDA advisory committee reforms, and concerns about the COVID-19 vaccine strain selection process.